BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22834082)

  • 1. Drug development of intranasally delivered peptides.
    Campbell C; Morimoto BH; Nenciu D; Fox AW
    Ther Deliv; 2012 Apr; 3(4):557-68. PubMed ID: 22834082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
    Phukan K; Nandy M; Sharma RB; Sharma HK
    Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From nose to brain: understanding transport capacity and transport rate of drugs.
    Wu H; Hu K; Jiang X
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
    Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
    Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective.
    Landis MS; Boyden T; Pegg S
    Ther Deliv; 2012 Feb; 3(2):195-208. PubMed ID: 22834197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of intranasally delivered peptides: key considerations for pharmaceutical development.
    Al Bakri W; Donovan MD; Cueto M; Wu Y; Orekie C; Yang Z
    Expert Opin Drug Deliv; 2018 Oct; 15(10):991-1005. PubMed ID: 30173579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
    Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent patents review on intranasal administration for CNS drug delivery.
    Jogani V; Jinturkar K; Vyas T; Misra A
    Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-based oral peptide nanomedicines.
    Herrero EP; Alonso MJ; Csaba N
    Ther Deliv; 2012 May; 3(5):657-68. PubMed ID: 22834409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
    Sintov AC; Levy HV; Botner S
    J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability issues in nasal drug delivery.
    Arora P; Sharma S; Garg S
    Drug Discov Today; 2002 Sep; 7(18):967-75. PubMed ID: 12546871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravail: highly effective intranasal delivery of peptide and protein drugs.
    Maggio ET
    Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and new strategies for therapeutic peptide delivery to the CNS.
    McGowan JW; Bidwell GL; Vig PJ
    Ther Deliv; 2015 Jul; 6(7):841-53. PubMed ID: 26228775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal drug delivery in humans.
    Bitter C; Suter-Zimmermann K; Surber C
    Curr Probl Dermatol; 2011; 40():20-35. PubMed ID: 21325837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of leucine enkephalin in the nasal cavity of the rat--a possible factor in the low bioavailability of nasally administered peptides.
    Hussain A; Faraj J; Aramaki Y; Truelove JE
    Biochem Biophys Res Commun; 1985 Dec; 133(3):923-8. PubMed ID: 4084310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism in the nasal mucosa.
    Sarkar MA
    Pharm Res; 1992 Jan; 9(1):1-9. PubMed ID: 1589391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
    Kashyap K; Shukla R
    Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.